Achieve optimal market access in a complex pricing environment
The PRMA Expert Advisory Group on Complex Pricing has proudly gained an international reputation for improving the complex pricing strategies of leading pharmaceutical and biotechnology companies with products in development or facing complex pricing challenges.
Providing you with access to a unique global community of the most experienced, multi-disciplinary experts, the PRMA EAGCP enables you to identify opportunities, generate and test solutions, accelerate decision-making, and realize optimal market access for your products.
Improve your understanding of commonalities and differences across countries, from consultation with expert payer and policy advisors, technical professionals, and clinicians.
Strengthen your approach at pivotal stages during planning by connecting your strategy with specialist evaluation and insight.
Elevate the quality of your decision-making by providing detailed and specific feedback on alternative options for complex pricing.
Accelerate internal alignment and agility throughout your commercialization process, through regular meetings with a consistent, cross-functional advisor group.
Optimize your resources to focus on product strategy as adept and compliant meeting implementation provides clear and comprehensive insight.
Capitalize on the breadth and depth of expertise of our global consulting team to deftly deliver your end goal on time and on budget.
Innovate robust strategies and solutions, through engagement with an advisor team that brings a pragmatic approach to solving your complex pricing challenges.
Maximize opportunities and address key risks for pricing strategies from the perspective of multiple stakeholders.
Advance decision-making with clear-cut deliverables that provide critical analysis, interpretation, and recommendations.
Thank you for the insightful advisory board. The mix of advisors was excellent: high quality, experienced, and engaged. The outcomes were crystal clear and I am looking forward to the summary.
The team did an exceptional job. The experts were very engaged and we learned a lot about how our data is likely to be perceived.